Adelis Health signs distribution agreement for late-stage pharmaceutical

Adelis Health has entered into a distribution agreement with an Australian pharmaceutical company for a pharmaceutical currently in late-stage clinical development.

Subject to regulatory approval, Adelis Health will support the product’s commercialisation and distribution in Australia.

The agreement expands Adelis Health’s portfolio and its role in bringing promising healthcare products from development through to commercial use.